Sabra Health Care REIT (SBRA) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual meeting scheduled for June 12, 2025, at company headquarters in Tustin, California.
Shareholders are invited to vote on key proposals, including director elections, executive compensation, and auditor ratification.
Voting matters and shareholder proposals
Election of seven directors is on the ballot, with all nominees recommended by the board.
Advisory vote on the compensation of named executive officers is included.
Ratification of PricewaterhouseCoopers LLP as the independent auditor for fiscal year ending December 31, 2025.
Additional business may be transacted as appropriate during the meeting.
Board of directors and corporate governance
Seven director nominees are listed: Craig A. Barbarosh, Katie Cusack, Michael J. Foster, Lynne S. Katzmann, Ann Kono, Jeffrey A. Malehorn, and Richard K. Matros.
Board recommends voting in favor of all director nominees.
Latest events from Sabra Health Care REIT
- Q4 2025 delivered strong managed senior housing growth and robust 2026 FFO/AFFO guidance.SBRA
Q4 202513 Feb 2026 - 2024 guidance raised as managed senior housing and FFO/AFFO growth accelerate.SBRA
Q2 20242 Feb 2026 - Q3 2024 saw strong earnings, raised guidance, and robust liquidity amid sector growth.SBRA
Q3 202417 Jan 2026 - 2024 saw strong AFFO growth and margins, with 2025 guidance projecting further FFO gains.SBRA
Q4 20248 Dec 2025 - Director elections, auditor ratification, and executive pay highlight strong governance and ESG.SBRA
Proxy Filing2 Dec 2025 - Q2 2025 saw higher earnings, strong senior housing growth, and raised 2025 guidance.SBRA
Q2 202523 Nov 2025 - Q1 2025 delivered higher earnings, strong FFO, and robust liquidity with major deals pending.SBRA
Q1 202519 Nov 2025 - Q3 2025 delivered strong managed senior housing growth, acquisitions, and a Moody's upgrade.SBRA
Q3 202513 Nov 2025